Aneurysmal dilatation proximal to longstanding arteriovenous fistulae (AF) is a known but not well-investigated phenomenon.
1-3 Hunter 4,5 first described the development of arterial dilatation from longstanding AF in 1757. Most of the arterial dilatation occurred after traumatic AF and aneurysmal progression even after ligation of the fistula was recorded. [6] [7] [8] [9] [10] [11] [12] [13] Possible explanations for these findings are increased flow in the vessel 14 and endothelium-derived factors. 15, 16 In our study, we investigated brachial arterial dilatation in patients after renal transplantation (rTPX) and long-lasting AF.
METHODS

Patient population.
In 1991, all patients after rTPX or planed transplantation were prospectively included in the study. They were followed until February 2001. All patients could be followed either until the end of the observation period or until the death of the patient. As a baseline investigation, diameters of brachial arteries of the left and the right upper extremities were recorded with ultrasound scan. In 1994 and 2001, control ultrasound scan was scheduled. As a control group, nine patients with longstanding AF without transplantation were examined. Dilatation of the brachial arteries was determined according to the definition by the subcommittee on reporting standards for arterial aneurysms. 17 Baseline data included patient demographics, smoking history, status, and kind of AF (Table I) .
Definition of outcomes. The primary outcome was the change of diameter of the brachial arteries. Secondary outcomes were time of occlusion (surgical or spontaneous) of AF and complications related to arterial dilatation. Only complications leading to surgical interventions were recorded.
Statistical analysis. The diameters of the brachial arteries were compared between sides with Wilcoxon signed rank test (nonparametric test). Correlation between diameter and patency of AF was calculated with the Spearmen test (nonparametric correlation). P values of less than .05 were considered significant.
RESULTS
Patient population. Twenty-nine patients after rTPX were included in the study. Twenty-six patients actually had undergone successful rTPX, and the other three were on a waiting list and underwent transplantation in the following year. As a control group, nine patients with longstanding AF were compared in 2002.
In to 74 years) in patients after rTPX and 61 years (Ϯ18 years; range, 34 to 81 years) in 2002 for patients without transplant (P ϭ not significant). Most of the AF were at the forearm (25 AF; 86%, in the group after rTPX; and five; 63%, without transplantation; Table II ). In the rTPX group in 1991, 20 AF were patent (69%) and the mean patency time was 72 months. In 1994 (2001), 14 AF (10) were still patent for a mean time of 109 (194) months (Table II) . The mean follow-up time in the control group was 86 months, and all AF were patent at the time of investigation.
Brachial artery dilatation. According to the suggestions of the subcommittee, the normal diameter of the brachial artery varies from 3.5 to 4.3 mm for women and from 4.1 to 4.8 mm for men. 17 In the group after rTPX, the mean brachial artery diameter at the side of the AF of all patients was, in 1991, 6.4 mm (Ϯ1.8 mm) if the access was patent and 5.2 mm (Ϯ1.5 mm) if it was occluded. In 1994, the diameter was 6.6 mm (Ϯ1.7 mm) versus 5.3 mm (Ϯ2.0 mm), and in 2001, it was 7.4 mm (Ϯ1.3 mm) versus 5.7 mm (Ϯ2.8 mm). In 1991, 1994, and 2001, the differences between artery diameters were significant whether the ac- cess was patent or occluded (Table III) . Comparison of the side with AF with the other side showed significant differences at all times (Table III) . There was a strong correlation between patency and arterial diameter according to the Spearman test (P ϭ .001; r ϭ 0.679; Fig 1) . The mean diameter of the brachial artery in the control group was 6.0 mm (Ϯ0.5 mm) at the side with AF compared with 4.4 mm (Ϯ0.6 mm) at the other arm (P ϭ .001; Table III ). Because dilatation is time dependent (Fig 1) , we compared the mean follow-up time in 1994 (109 months) with the mean follow-up time in the control group (86 months). The mean dilatation of the 14 patent AF (6.6 mm) at the group after rTPX was larger than dilatation at the control group (5.8 mm; Table III ) but did not reach significance.
In 2001, we had to operate on two patients with symptomatic aneurysmal dilatation of the brachial artery. One fistula was patent for 125 months, and one was occluded since 1994 but had been patent for 81 months. In both patients, distal embolic occlusions of peripheral arteries were present (Fig 2) . At operation, the aneurysms were resected and flow was established with construction of a bypass with greater saphenous vein.
DISCUSSION
The objective of this study was to compare brachial artery diameter in long-lasting AF. Dilatation of the artery proximal to fistulas is noticed either in patent or occluded fistulas.
2,3,6-8 The major part of these dilatations have been observed in traumatic fistulas. [9] [10] [11] [12] Only one publication recently reported a symptomatic aneurysmal dilatation of the axillobrachial artery after long-lasting hemodialysis access. 1 
Sako and Varco
14 reported in 1970 on a total of 57 AVFs. Thirty-two patients had congenital forms of AF, and 25 had acquired forms. They thought that the mechanism underlying dilatation to be from stress, high blood flow, and interference with the function of the vasa vasorum. Microscopic sections of the arterial wall of operated aneurysms proximal to AF did show fragmentation of the elastic tissue, atrophy of the muscles, increased fibrosis, intimal thickening, and calcification in some areas. The overall appearance of the artery was similar to that of an arteriosclerotic aneurysm. Even after removal of the AF, dilatation of the artery may progress. Therefore, they recommended an investigation of the artery in every patient with a fistula of long duration. In 1986, Miller, Aarhus, and Vanhoutte 15 and Rubanyi, Romero, and Vanhoutte 16 postulated a humoral influence. Rubanyi, Romero, and Vanhoutte 16 were able to show that flow triggered the release of relaxing substances from vascular endothelial cells that had characteristics similar to the endothelium-derived relaxing factor released by acetylcholine. The fact that only the side with the AF showed dilatation supports these findings and indicates a local rather than a systemic effect triggering dilatation of the artery.
Our data show a dilatation depending on time. This dilatation occurred despite half of all AF occluded during the study period at patients after rTPX. Yet the dilatation of the artery was significantly smaller if the AF was occluded, supporting the hypothesis of higher flow leading to arterial dilatation. This observation is further supported by the fact that the difference in arterial diameters also was significant at the control group without transplantation.
The patients after successful kidney transplantation consecutively received imunosuppression. Twenty-one pa- tients were receiving corticosteroids. Experimental evidence suggests that corticosteroids may promote both the development and rupture of aortic aneurysms. 18 Aneurysmal disease appears more common and develops 10 years earlier in patients receiving steroids for autoimmune disease. 19 Ammori and coworkers 20 recommend early repair in patients for cardiac transplant with aortic aneurysms.
Because there was a significant difference in arterial diameter of the arm with the fistula compared with the arm without fistula, we conclude that the fistula is the main trigger for dilatation of the artery. In our work, immunosuppression is of minor importance but may increase the total amount of dilatation.
The main limitation to our study is the small number of patients, making a type 2 statistical error possible. But the long follow-up period without loss of patients strengthened the statistical value of our results. The patients in the control group were not totally comparable with the transplant patients because more women and less patients with hypertension were included. Arterial diameters in women are smaller than those in men. 17 For that reason, it could be expected that a potential difference of diameters between the two groups would be influenced by the disproportional distribution of women at the control group. One can expect that the mean diameter would be greater at the control group if more men were included. Because the difference of mean diameters between the groups was not significant, it can be concluded that with inclusion of more men into the control group the results would be similar.
In summary, our findings support the observation that dilatation of the artery proximal to AF exists. The main trigger for this dilatation seems to be increased flow at the side of the AF. Immunosuppression after kidney transplantation may accelerate this process.
